Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Cuts Sales Reps By Reducing PDI Contract; Will Others Follow?

Executive Summary

AstraZeneca's decision to reduce the number of contract sales reps may be an early indicator of an industry trend in 2005

You may also be interested in...



Novartis To Maintain Sales Force In Face Of Potential Competitor Cutbacks

Novartis' decision to maintain its current sales force level could reflect the company's confidence in the continued growth of its pharmaceutical business

Novartis To Maintain Sales Force In Face Of Potential Competitor Cutbacks

Novartis' decision to maintain its current sales force level could reflect the company's confidence in the continued growth of its pharmaceutical business

Sales Force Downsizing By Big Pharma Means Small/Mid-Tier Boom, CSOs Say

Sales force restructuring among large pharmaceutical companies is helping to drive contract sales agreements with small and mid-tier companies, contract sales organizations say

Related Content

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel